Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-13.73%
|
$1,190,000
$119.74 P/Share
|
|
Jan 14
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Jan 07
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$774,700
$122.16 P/Share
|
|
Jan 07
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Jan 06
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.38%
|
-
|
|
Jan 06
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.1%
|
$4,036,200
$124.37 P/Share
|
|
Jan 06
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.37%
|
-
|
|
Jan 06
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Dec 22
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Bona fide gift
|
Direct |
1,000
+1.71%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.38%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.12%
|
$3,873,450
$119.28 P/Share
|
|
Dec 20
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.52%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Dec 17
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-26.73%
|
$1,210,000
$121.24 P/Share
|
|
Dec 17
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Dec 10
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-3.05%
|
$768,350
$121.75 P/Share
|
|
Dec 10
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Dec 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.28%
|
$1,337,050
$121.75 P/Share
|
|
Dec 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Dec 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-3.81%
|
$947,430
$121.49 P/Share
|
|
Dec 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+3.67%
|
$274,050
$35.2 P/Share
|
|
Nov 29
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$11,000
$110.58 P/Share
|
|
Nov 29
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.07%
|
$2,100
$21.76 P/Share
|
|
Nov 24
2021
|
Nicholas J Valeriani Director |
BUY
Open market or private purchase
|
Direct |
1,500
+2.3%
|
$168,000
$112.23 P/Share
|
|
Nov 18
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-9.59%
|
$1,170,000
$117.91 P/Share
|
|
Nov 18
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Nov 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$931,770
$119.79 P/Share
|
|
Nov 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Nov 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Nov 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.67%
|
$3,873,450
$119.93 P/Share
|
|
Nov 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Nov 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Nov 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$755,650
$119.4 P/Share
|
|
Nov 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Nov 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.54%
|
$1,292,850
$117.24 P/Share
|
|
Nov 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Oct 18
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
9,741
-13.83%
|
$1,071,510
$110.56 P/Share
|
|
Oct 18
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
9,741
+20.77%
|
$204,561
$21.76 P/Share
|
|
Oct 11
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$845,640
$108.0 P/Share
|
|
Oct 11
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Oct 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$698,500
$110.91 P/Share
|
|
Oct 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Oct 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.2%
|
$1,215,500
$110.77 P/Share
|
|
Oct 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Oct 01
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Oct 01
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.11%
|
$3,645,600
$112.2 P/Share
|
|
Oct 01
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.37%
|
-
|
|
Oct 01
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Sep 15
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Sep 15
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.46%
|
$3,906,000
$120.91 P/Share
|